Evogene Ltd. — Report Publication Announcement 2025

Apr 21, 2025

ICL to Acquire the Activity of Evogene�s Subsidiary, Lavie Bio false

����� ��"�	2 380
EVOGENE LTD
Corporation no: 512838723	13041
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	21/04/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-028186	Time of broadcast: 11:50 11:50

---

The corporation scheduled the publication of the report to 21/04/2025 14:00Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onICL to Acquire the Activity of Evogene�s Subsidiary, Lavie Bio

1745224326_6K_and_PR_Lavie_Bio_ICL_21-4_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: ofer.haviv@evogene.com   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company:
Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: guy.kofman@evogene.com 1